SYNTHESIS OF ETIOCHOLANOLONE FOR USE IN APLASTIC ANEMIA

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 2958
Amount: $495,000.00
Phase: Phase II
Program: SBIR
Awards Year: 1986
Solitcitation Year: N/A
Solitcitation Topic Code: N/A
Solitcitation Number: N/A
Small Business Information
Progenics, Inc.
442 West 44nd Street, New York, NY, 10036
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Norman Applezweig
 Principal Investigator
 (212) 265-0650
Business Contact
Phone: () -
Research Institution
N/A
Abstract
THE USE OF -ETIOCHOLANOLONE AND -ETIOCHOLANOLONE IN APLASTIC ANEMIA SHOWS PROMISE, BUT THE SUPPLY IS VERY LIMITED DUE TO THE LACK OF A GOOD SYNTHESIS FROM READILY AVAILABLE MATERIAL. -ETIOCHOLANOLONE WOULD BE LESS TRAUMATIC TO THE PATIENT, BUT IS NOT READILY AVAILABLE AGAIN FOR THE ABOVE MENTIONED REASON. DURING PHASE I, REASONABLE AND ECONOMIC SYNTHESES OF -ETIOCHOLANOLONE AND -ETIOCHOLANOLONE FROM READILY AVAILABLE RAW MATERIALS HAVE BEEN SUCCESSFULLY DEVELOPED THUS PERMITTING THE SYNTHESIS OF SUFFICIENT QUANTITIES OF THESE AGENTS FOR LARGE-SCALE CLINICAL TRIALS. PHASE II FUNDS ARE BEING SOUGHT TO CARRY OUT CLINICAL TRIALS IN APLASTIC ANEMIA AS WELL AS TOXICOLOGY STUDIES WITH COMPETENT INVESTIGATORS.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government